Virax Biolabs News

Virax Biolabs | 6-K: Virax Biolabs Group Limited to Participate at ESCMID Global 2024

Apr 16 07:39 ET

Virax Biolabs | 6-K: Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Mar 15 22:33 ET

Virax Biolabs | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Feb 14 15:58 ET

Virax Biolabs | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 22 00:00 ET

Virax Biolabs | 424B5: Prospectus

Jan 22 00:00 ET

Virax Biolabs | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 12 00:00 ET

Virax Biolabs | 6-K: Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in Covid Patients

Dec 21, 2023 07:34 ET

Virax Biolabs | 424B3: Prospectus

Dec 20, 2023 16:12 ET

Virax Biolabs | 6-K: Third Amended and Restated Memorandum of Association

Dec 20, 2023 16:06 ET

Virax Biolabs | 424B3: Prospectus

Dec 20, 2023 16:03 ET

Virax Biolabs | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 18, 2023 07:37 ET

Virax Biolabs | EFFECT: Others

Dec 18, 2023 00:15 ET

Virax Biolabs | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 14, 2023 07:43 ET

Virax Biolabs | CORRESP: CORRESP

Dec 13, 2023 00:00 ET

Virax Biolabs | UPLOAD: Others

Dec 12, 2023 00:00 ET

Virax Biolabs | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 8, 2023 06:03 ET

Virax Biolabs | F-3: Registration statement for specified transactions by certain foreign private issuers

Dec 5, 2023 16:06 ET

Virax Biolabs | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 8, 2023 16:11 ET

Virax Biolabs | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 31, 2023 16:38 ET

Virax Biolabs | D: Filing D

Oct 17, 2023 16:05 ET